New Technologies and Applications in Sacral Neuromodulation: An Update Stefan De WachterCharles H. KnowlesPhilip E. V. Van Kerrebroeck Commentary Open access 24 December 2019 Pages: 637 - 643
Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature André FarkouhThomas RiedlAlexandra Kautzky-Willer Review 23 December 2019 Pages: 644 - 655
Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review Daniel E. HillemanBarbara S. WigginsMichael B. Bottorff Review Open access 09 January 2020 Pages: 656 - 670
Analgesic Impact of Single-Shot Versus Continuous Femoral Nerve Block After Total Knee Arthroplasty: A Systematic Review and Meta-Analysis Shiyi LiJinpeng ZhouJunchao Zhu Review 10 January 2020 Pages: 671 - 685
Peripheral Vascular Disease and Implication of Nursing Practice: A Brief Literature Review Qin FanYan LiuHongwei Lei Review 17 January 2020 Pages: 686 - 691
Development of a Conceptual Model of Chronic Hand Eczema (CHE) Based on Qualitative Interviews with Patients and Expert Dermatologists Laura GrantLotte Seiding LarsenRob Arbuckle Review Open access 19 January 2020 Pages: 692 - 706
Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study Yuichi OhashiMasahiro MunesueFumiki Shimada Original Research Open access 13 December 2019 Pages: 707 - 717
Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma David J. JacksonMarc HumbertEsther Garcia Gil Original Research Open access 14 December 2019 Pages: 718 - 729
Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis Kirsi M. ManzKlaus FenchelWolfram C. M. Dempke Original Research Open access 14 December 2019 Pages: 730 - 744
The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants Joseph ChenHuiping XuYazdi K. Pithavala Original Research 20 December 2019 Pages: 745 - 758
Observational Study of Sequential Afatinib and Osimertinib in EGFR Mutation-Positive NSCLC: Patients Treated with a 40-mg Starting Dose of Afatinib Nobuyuki YamamotoTakeshi MeraMaximilian J. Hochmair Original Research Open access 20 December 2019 Pages: 759 - 769
Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal Nermina FerizovićJade MarshallSheela Upadhyaya Original Research Open access 21 December 2019 Pages: 770 - 784
Treatment of Atrial Fibrillation Using Ablation Index-Guided Contact Force Ablation: A Matching-Adjusted Indirect Comparison to Cryoballoon Ablation Ahmed HusseinDhiraj GuptaGiuseppe Stabile Original Research Open access 21 December 2019 Pages: 785 - 799
Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis Petri MankinenTuomas LundströmElina Järvinen Original Research Open access 23 December 2019 Pages: 800 - 818
A Longitudinal Study of the Association of Opioid Use with Change in Pain Interference and Functional Limitations in a Nationally Representative Cohort of Adults with Osteoarthritis in the United States Drishti ShahXiaohui ZhaoUsha Sambamoorthi Original Research Open access 24 December 2019 Pages: 819 - 832
Risk of Long-Term Mortality for Complex Chronic Patients with Intracerebral Hemorrhage: A Population-Based e-Cohort Observational Study Maria Antonia González-HenaresJose Luis Clua-EspunyJose Vicente Gil-Guillen Original Research 26 December 2019 Pages: 833 - 846
Model-Based Cost-Effectiveness Analysis of Panitumumab Plus FOLFIRI for the Second-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer Yin ShiXiaomin WanLiubao Peng Original Research 04 January 2020 Pages: 847 - 859
Screening and Follow-Up of Acute ROP: Reproducibility of Fluorescein Angiography Donatella BarillàRosanna GuaglianoLuciano Quaranta Original Research 08 January 2020 Pages: 860 - 868
Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States Sarah Naz AliTam Dang-TanBrian Bekker Hansen Original Research Open access 10 January 2020 Pages: 869 - 882
Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries Jana PodhornaNadine WinterSusann Walda Original Research Open access 13 January 2020 Pages: 883 - 893
Alzheimer’s Treatment: Real-World Physician Behavior Across Countries Jana PodhornaNadine WinterThomas Perkins Original Research Open access 13 January 2020 Pages: 894 - 905
Safety and Efficacy of Combined Oral Contraceptive Ethinyl Estradiol/Drospirenone (YAZ) in Chinese Women: A Single-Arm, Open-Label, Multicenter, Post-Authorization Study Xin SunFangbo QianWen Di Original Research 16 January 2020 Pages: 906 - 917
Decreasing the Peril of Antimicrobial Resistance Through Enhanced Health Literacy in Outpatient Settings: An Underrecognized Approach to Advance Antimicrobial Stewardship Elizabeth D. HermsenErina L. MacGeorgeBernard M. Rosof Original Research Open access 17 January 2020 Pages: 918 - 932
Levothyroxine Treatment of Pregnant Women with Hypothyroidism: Retrospective Analysis of a US Claims Database Maureen J. LageJamie VoraRamon Espaillat Original Research Open access 18 January 2020 Pages: 933 - 945
Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors Eric NadlerMelissa PavilackAncilla Fernandes Original Research 18 January 2020 Pages: 946 - 954
Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et al. Adv Ther (2019);36(8):2147–2160. doi:10.1007/s12325-019-00991-w Jinlin SongWei GaoSimran Tiwana Letter Open access 14 December 2019 Pages: 955 - 957
Response to Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia Irina ProskorovskyErik VandendriesMatthias Stelljes Letter Open access 14 December 2019 Pages: 958 - 962
Letter to the Editor in Response to “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally” Aaron LazorwitzChristina L. AquilanteStephanie Teal Letter Open access 24 December 2019 Pages: 963 - 964
Author’s Response to: ‘Letter to the Editor in Response to: “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”’ Pablo ZubiaurMiriam Saiz-RodríguezFrancisco Abad-Santos Letter Open access 24 December 2019 Pages: 965 - 967
Letter: Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small-Cell Lung Cancer in China Lifeng MuBenhong Zhou Letter Open access 04 January 2020 Pages: 968 - 970
Response Letter to “Letter: Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China” Haijing GuanYanan ShengLuwen Shi Letter Open access 04 January 2020 Pages: 971 - 972
Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine Yehuda HandelsmanMarcel H. A. MuskietGraydon S. Meneilly Correction Open access 23 December 2019 Pages: 973 - 973
Correction to: Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease Ariel BergerAlex SimpsonJeffrey Berger Correction 13 January 2020 Pages: 974 - 974
Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies Daphne T. AdelmanDirk Van GenechtenWendy A. Martin Correction Open access 18 January 2020 Pages: 975 - 976